1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...
New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...
Regeneron beat Q4 earnings and sales estimates as Dupixent gains offset weaker Eylea sales. The drugmaker also outlined 2026 ...
Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...
Regeneron Pharmaceuticals, Inc. Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter 2024; full year 2025 revenues increased 1% to $14.3 billion versus ...
Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the ...
Hollywood actress Cameron Diaz (53) appeared on the red carpet after a long absence, capturing attention with her unchanged beauty. According to the Daily Mail's report on the 10th (local time), ...
Hosted on MSN
Death by firing squad set to resume in the US, but all means of execution come with a troubling history
Barring any late developments, the U.S. is set to see its first execution by firing squad in 15 years on March 7, 2025. Photos released by the South Carolina Department of Corrections suggest that the ...
In an interview with The Times about their beauty regimes and favourites, during which the determined teen revealed her plans: 'I will definitely have lip filler when I’m 18. Just half a millilitre.
Born after five rounds of IVF and two miscarriages, Henley entered the world with an extremely rare condition known as bilateral fibular hemimelia and is expected to undergo lower-leg amputation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results